Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ijcp.12995 http://scihub22266oqcxt.onion/10.1111/ijcp.12995 C5698762!5698762!28980739     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Clin+Pract 2017 ; 71 (11): ä Nephropedia Template TP {{tp|p=28980739|t=2017. Serum testosterone levels in male hypogonadism: Why and when to check?A review |pdf=|usr=}}{{28980739}} gab.com Text Serum testosterone levels in male hypogonadism: Why and when to check A review JO: Int J Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=28980739 #FOAvip Aim: Although ?late onset hypogonadism?, a condition that includes low testosterone and symptoms, is common in men over the age of 40 years, diagnosis is not clear cut amongst non?specialists. It is the aim of this review to provide an up to date picture of how this state should be diagnosed and managed. Methods: We aim to describe how primary and secondary hypogonadism should be excluded before the diagnosis of late onset hypogonadism is reached. As laboratory testosterone measurements are essential the current pitfalls such as inappropriate sample collection and the use of population derived reference ranges are expanded. We review current evidence to determine associations between late onset hypogonadism and morbidity/mortality and benefits following testosterone replacement therapy. Results: A review of the current evidence shows that late onset hypogonadism is associated with a worse metabolic state and increased mortality. Longitudinal studies have suggested that significant reductions in both symptoms and mortality are seen, especially in patients with type 2 diabetes. Discussion: This review highlights the importance of diagnosing late onset hypogonadism due to its association with morbidity/mortality and benefits following testosterone replacement. Thus, after making recommendations to ensure correct diagnosis we speculate whether the time has come to move away from population derived testosterone levels towards evidence based action limits. Twit Text FOAVip Serum testosterone levels in male hypogonadism: Why and when to check A review ????Int J Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=28980739 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28980739 #FOAvip English Wikipedia <ref>{{Cite pmid|28980739}}</ref> Serum testosterone levels in male hypogonadism: Why and when to check?A review #MMPMID28980739 Livingston M; Kalansooriya A; Hartland AJ; Ramachandran S; Heald A Int J Clin Pract 2017[Nov]; 71 (11): ä PMID28980739show ga Aim: Although ?late onset hypogonadism?, a condition that includes low testosterone and symptoms, is common in men over the age of 40 years, diagnosis is not clear cut amongst non?specialists. It is the aim of this review to provide an up to date picture of how this state should be diagnosed and managed. Methods: We aim to describe how primary and secondary hypogonadism should be excluded before the diagnosis of late onset hypogonadism is reached. As laboratory testosterone measurements are essential the current pitfalls such as inappropriate sample collection and the use of population derived reference ranges are expanded. We review current evidence to determine associations between late onset hypogonadism and morbidity/mortality and benefits following testosterone replacement therapy. Results: A review of the current evidence shows that late onset hypogonadism is associated with a worse metabolic state and increased mortality. Longitudinal studies have suggested that significant reductions in both symptoms and mortality are seen, especially in patients with type 2 diabetes. Discussion: This review highlights the importance of diagnosing late onset hypogonadism due to its association with morbidity/mortality and benefits following testosterone replacement. Thus, after making recommendations to ensure correct diagnosis we speculate whether the time has come to move away from population derived testosterone levels towards evidence based action limits. äSerum testosterone levels in male hypogonadism: Why and when to check?(epmc).pdf DeepDyve Pubget Overpricing